Loading...
Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies
SIMPLE SUMMARY: Epidermal growth factor receptor (EGFR) mutations occur in a significant number of lung cancer patients. Treatment outcomes in this subset of patients has greatly improved over the last decade after the introduction of EGFR tyrosine kinase inhibitors (TKIs), which demonstrated high e...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8267708/ https://ncbi.nlm.nih.gov/pubmed/34202748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133164 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|